Unit:
|
Investment Service Center, Quanzhou Development Zone
|
![]() |
Project Area:
|
quanzhou Medical Industrial Base of Quanzhou Development Zone
|
|
Industry:
|
Biological and New Pharmaceutical Industry
|
|
Type of Project:
|
New Project
|
|
Cooperation Mode:
|
Collaborate
|
|
Nature of Project:
|
Encourage
|
|
Working Progress in Prior Period:
|
none
|
|
Total Investment:
|
discussed in detai
|
|
Expected to Attract Investment:
|
discussed in detai
|
|
Benefit Analysis:
|
none
|
|
Reason and Condition:
|
none
|
|
Content and Scale:
|
It plans to introduce chemical drug R&D and production enterprises and establish a joint drug marketing group.
|
|
Others:
|
none
|
Biological & New Pharmaceutical Industry
In 2024, Fujian Province had 344 pharmaceutical enterprises above designated size, generating a total revenue of RMB 60.84 billion. Our province has established a relatively comprehensive pharmaceutical industrial system, covering categories such as chemical APIs (active pharmaceutical ingredients), chemical drug preparations, biopharmaceuticals, traditional Chinese medicine (TCM) preparations, TCM decoction pieces, and medical devices. The biopharmaceutical industry in Fujian Province is primarily concentrated in Xiamen, Sanming, Fuzhou, and Zhangzhou, with these four cities accounting for approximately 80% of our province's total revenue.